Navigation Links
BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference

common cold and some other respiratory infections, seasonal flu can cause severe illness, resulting in life-threatening complications. According to the Centers for Disease Control and Prevention, every year in the United States more than 200,000 people are hospitalized from flu complications, and about 36,000 people die from flu. Most at risk are young children, the elderly, and people with seriously compromised immune systems.

Avian influenza A viruses of H5N1 subtype are circulating among birds worldwide, the virus is considered extremely contagious in fowl. It is believed that all species of birds are susceptible to avian influenza, but domestic poultry, including chickens and turkeys, are among the more susceptible to the highly pathogenic strain. According to the World Health Organization, at least 261 people have contracted H5N1 avian influenza, of which at least 157 have died. Almost all of these infections are believed to have resulted from contact with infected poultry.

About BioCryst

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine(TM) in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization of BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine(TM) in markets across Europe, Asia, Australia and certain neighboring countries. In January, 2007 the U.S. Department of Health and Human Services (DHHS) awarded a $102.6 million, four-year contract to BioCryst for advanced development of peramivir to treat seasonal and life-threatening influenza. In Februar
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. Solstice Neurosciences Presents Escalating Dose Study at International Congress in Istanbul, Turkey
Post Your Comments:
(Date:4/17/2015)... -- ASSESS shows   plasma circulating tumour ... alternative to tumour biopsy   IGNITE supports ... NSCLC   AstraZeneca today presented results from two ... (ctDNA) testing for epidermal growth factor receptor (EGFR) mutation status ... (NSCLC) in clinical practice. [ 1 ] ...
(Date:4/17/2015)... DETROIT , April 17, 2015  In Detroit, where ... infant mortality rate is two and one half times of ... Nearly 6 of 10 infants that die in ... are sobering statistics that Covenant Community Care, a faith-based, charitable ... is poised to change thanks to a charitable donation by ...
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... "Medical Oxygen Systems - Global Strategic Business Report" ... analyzes the worldwide markets for Medical Oxygen Systems in ... Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving ... US, Canada , Japan ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2
(Date:4/18/2015)... Montreal, Canada (PRWEB) April 18, 2015 ... of emotions on food choices when he uttered, “Tell ... what you are.” Using food to cope with stress ... research by Queendom.com indicates otherwise. Data collected ... both genders fall victim to emotional eating, but for ...
(Date:4/17/2015)... Lynnwood, WA (PRWEB) April 17, 2015 ... seat cushions is introducing two new products to help ... seeking low back pain relief are the second most ... was our first product, designed specifically to help relieve ... the Comfort Cushion, and thousands of happy customers later, ...
(Date:4/17/2015)... 17, 2015 “We have seen healing, a ... past and present,” said Chaplain Shawn Kafader of Friendship Village. ... like they had anything to contribute have created beautiful pieces ... a new art therapy program that was launched to benefit ... student from School of the Art Institute in Chicago, worked ...
(Date:4/17/2015)... 17, 2015 Representatives Jim Himes (D-CT) ... Treatment Act HR 1849 in congress on April 16, ... treatment for patients with the genetic disease. , ... would be the first to create a federally led ... of hereditary hemorrhagic telangiectasia. This would effectively prevent premature ...
(Date:4/17/2015)... Fla. (PRWEB) April 17, 2015 Most ... of dental restoration units are made overseas by foreign ... Additionally, domestic labs remain unregulated in more than 40 ... The National Association of Dental Laboratories has ... to raise awareness among patients about the consequences that ...
Breaking Medicine News(10 mins):Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Healing At Friendship Village Due To Art Therapy 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:National Association Urges Transparency in Dental Industry 2
... and treatment of genitourinary cancers were released today in advance ... 17-19, 2011, at the Orlando World Center Marriott in Orlando, ... a media presscast (press briefing via live webcast): ... death for men with low initial PSAs: A large prostate ...
... TUESDAY, Feb. 15 (HealthDay News) -- Men with prostate cancer may ... pattern baldness at the age of 20 than those without prostate ... their hair in their 30s or 40s do not appear to ... hair loss starts in their 20s do not face a higher ...
... of all the imaging costs ordered for 2,068 orthopaedic patient ... a new study presented today at the 2011 Annual Meeting ... For many years now, some physicians have ordered specific ... a patient, largely to protect themselves from a lawsuit. ...
... to lose hair at the age of 20 are more likely ... screening for the disease, according to a new study published online ... The French study compared 388 men being treated for ... found that those with the disease were twice as likely as ...
... HealthDay Reporter , TUESDAY, Feb. 15 (HealthDay News) ... restaurants doesn,t appear to inspire teenagers and parents of ... Researchers who studied menu choices at four fast-food restaurant ... New York City said the legislation did little to ...
... An estimated 10 million Americans suffer from knee osteoarthritis ... disability in the US. Due to obesity and symptomatic knee ... the equivalent of 86 million healthy years of life, concluded ... potential gains in quality and quantity of life that could ...
Cached Medicine News:Health News:Research presented at 2011 GU Cancers Symposium highlights advances in treatment of prostate cancer 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 3Health News:Health care spending: Study shows high imaging costs for defensive purposes 2Health News:Health care spending: Study shows high imaging costs for defensive purposes 3Health News:Losing hair at 20 is linked to increased risk of prostate cancer in later life 2Health News:Losing hair at 20 is linked to increased risk of prostate cancer in later life 3Health News:Calorie Labels Don't Affect Kids' Fast-Food Choices 2Health News:Calorie Labels Don't Affect Kids' Fast-Food Choices 3Health News:Obesity and knee osteoarthritis shorten healthy years of life 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: